Patent ID: 7098226

Claim:
A compound selected from the group consisting of 1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)-propyl]urea, 1-[2-(1-adamantyl)ethyl]-3-[-3-(4-pyridyl)propyl]-1-(3,3,3-trifluoropropyl)urea, 1-[2-(1-adamantyl)ethyl]-1-(2-butenyl)-3-[3-(4-pyridyl)propyl]urea, 1-[2-(1-adamantyl)ethyl]-1-[2-[N-(t-butoxycarbonyl)-N-methylamino]ethyl]-3-[3-(4-pyridyl)propyl]urea, 1-[3-(1-adamantyl)propyl]-1-propyl-3-[3-(4-pyridyl)propyl]urea, (Z)-1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)-2-propenyl]urea, (−)-1-[2-(1-adamantyl)ethyl]-3-[2-methyl-3-(4-pyridyl)propyl]-1-pentylurea, 1-[2-(1-adamantyl)ethyl]-3-[1-methyl-3-(4-pyridyl)propyl]-1-pentylurea, (+)-1-[2-(1-adamantyl)ethyl]-1-[2-[N-(t-butoxycarbonyl)-N-methylamino]ethyl]-3-[2-methyl-3-(4-pyridyl)propyl]urea, cis-1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[2-(4-pyridyl)cyclopropylmethyl]urea, 1-[2-(1-adamantyl)ethyl]-3-[2-methyl-3-(4-pyridyl)propyl]-1-pentylurea, 1-[2-(1-adamantyl)ethyl]-1-[2-N-(t-butoxycarbonyl)-N-methylamino]ethyl]-3-[2-methyl-3-(4-pyridyl)propyl]urea, (E)-1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)-2-propenyl]urea and (+)-1-[2-(1-adamantyl)ethyl]-3-[2-methyl-3-(4-pyridyl)propyl]1-pentylurea and a pharmacologically acceptable salt thereof.